BIBR1591 INDUCES APOPTOSIS IN BREAST CANCER CELL LINE AND INCREASES EXPRESSION OF DAPK1, AND NR4A3
Z Alsarraf1, A Nori2, A Oraibi3
11Department of Pharmaceutical Chemistry, College of Pharmacy, Nineveh University, Iraq.
Georgian Medical News
|January 24, 2025
Summary
BIBR1591, a telomerase inhibitor, effectively reduced breast cancer cell viability and induced apoptosis. It also upregulated CDH13, DAPK1, and NR4A3 gene expression, supporting its therapeutic potential.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Breast cancer is a leading cause of death in women, often driven by ovarian hormones.
- Telomerase inhibitors are investigated for cancer therapy.
- BIBR1591 is a potent small molecule telomerase inhibitor effective at low concentrations.
Purpose of the Study:
- To investigate the molecular mechanisms of BIBR1591 in breast cancer.
- To assess BIBR1591's ability to induce apoptosis and modify gene expression.
- To understand BIBR1591's potential as a breast cancer therapeutic.
Main Methods:
- MCF-7 breast cancer cells were treated with BIBR1591.
- Cell viability was assessed using MTT assay.
- Apoptosis was measured by flow cytometry.
- Gene expression of CDH13, DAPK1, and NR4A3 was analyzed via qPCR.
Main Results:
- BIBR1591 demonstrated a dose-dependent reduction in MCF-7 cell viability.
- Significant induction of apoptosis was observed in treated cells.
- Expression of CDH13, DAPK1, and NR4A3 genes was upregulated by BIBR1591.
Conclusions:
- BIBR1591 exhibits unique anticancer effects by modulating CDH13, DAPK1, and NR4A3 gene expression.
- These findings suggest BIBR1591 as a promising therapeutic agent for breast cancer.
Related Concept Videos
01:31The Intrinsic Apoptotic Pathway
6.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
02:26NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
02:34Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
01:17The Extrinsic Apoptotic Pathway
6.1K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.1K
01:07MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K